Literature DB >> 2898463

Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV.

K Ikuta1, C Morita, M Nakai, N Yamamoto, S Kato.   

Abstract

Persistently HIV-infected cell lines were isolated from surviving and proliferating cells after infection of HTLV-I-carrying MT-4 cells with cell-free human immunodeficiency virus (HIV); HTLV-IIIB and LAV. The media of the cloned cell cultures did not cause HIV infection of MT-4, MOLT-4, TALL-1, or HL-60 cells. Most of the constituents of the virus in the media were env proteins and many defective doughnut-shaped particles released from the cells were identified by electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898463      PMCID: PMC5917499          DOI: 10.1111/j.1349-7006.1988.tb01607.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.

Authors:  A De Rossi; G Franchini; A Aldovini; A Del Mistro; L Chieco-Bianchi; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

3.  A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.

Authors:  T H Lee; J E Coligan; J S Allan; M F McLane; J E Groopman; M Essex
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

4.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

5.  Amplification of human immuno-deficiency virus production from a virus-producing cell line in culture at high cell density.

Authors:  K Ikuta; H Imai; S Ueda; S Suehiro; N Yamamoto; S Kato
Journal:  Jpn J Cancer Res       Date:  1987-07

6.  Effect of HTLV-III on the macromolecular synthesis in HTLV-I carrying cell line, MT-4.

Authors:  H Nakashima; Y Koyanagi; S Harada; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

7.  Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin.

Authors:  K Ikuta; R B Luftig
Journal:  Virology       Date:  1986-10-15       Impact factor: 3.616

8.  Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines.

Authors:  Y Koyanagi; S Harada; M Takahashi; F Uchino; N Yamamoto
Journal:  Int J Cancer       Date:  1985-10-15       Impact factor: 7.396

9.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

10.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.

Authors:  T M Folks; D Powell; M Lightfoote; S Koenig; A S Fauci; S Benn; A Rabson; D Daugherty; H E Gendelman; M D Hoggan
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  8 in total

1.  Characterization of human T-cell lines harboring defective human immunodeficiency virus type 1.

Authors:  Y Hamamoto; K Takamatsu; S Kobayashi; K Yamaguchi; N Yamamoto; N Kobayashi
Journal:  Virus Genes       Date:  1989-11       Impact factor: 2.332

2.  Inhibition of HIV-1 replication and syncytium formation by synthetic CD4 peptides.

Authors:  Y Hayashi; K Ikuta; N Fujii; K Ezawa; S Kato
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 3.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

4.  A defective proviral DNA with a 2.6-kb deletion of human immunodeficiency virus type 1 (HIV-1) in a persistently HIV-1 infected cell clone.

Authors:  H Imai; K Maotani-Imai; Y S Shin; K Ikuta; S Suehiro; T Kurimura; S Kato; K Hirai
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

5.  Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.

Authors:  M Yunoki; K Maotani-Imai; H Kusuda; M Motoyama; S Miyake; H Imai; Y S Shin; S Kato; K Sano; C Morita
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.

Authors:  T Goto; K Ikuta; J J Zhang; C Morita; K Sano; M Komatsu; H Fujita; S Kato; M Nakai
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.

Authors:  Masanobu Kinomoto; Masaru Yokoyama; Hironori Sato; Asato Kojima; Takeshi Kurata; Kazuyoshi Ikuta; Tetsutaro Sata; Kenzo Tokunaga
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells.

Authors:  Y Nishino; M Kishi; M Sumiya; K Ogawa; A Adachi; K Maotani-Imai; S Kato; K Hirai; K Ikuta
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.